Three of the six human clinical samples displayed markedly increased expression levels of OTULIN in breast cancerous tissue (BC) compared with adjacent normal tissue (N), which correlated with the up-regulated OTULIN dimerization and linear deubiquitination and almost demolished the interaction with HOIP(Fig. 6 A–C, red arrows, group A). This evidence concerns the gene OTULIN and breast cancer.